Interaction of talinolol and sulfasalazine in the human gastrointestinal tract |
| |
Authors: | B. Terhaag U. Palm H. Sahre K. Richter R. Oertel |
| |
Affiliation: | (1) Department of Clinical Pharmacology, Medical Academy of Dresden, Dresden, Germany |
| |
Abstract: | Summary The absorption of talinolol (TA) 50 mg was investigated without and together with the co-administration of sulfasalazine (SASP) 4 g in 11 healthy young volunteers, in order to clarify gastrointestinal transit of TA.Without SASP, the tmax of TA was 2.8 h, Cmax was 112 ng·ml–1 and the half life was 12 h; the AUCo-t was 958 ng·ml–1·h.In the case of concomitant administration of SASP, TA was found only in serum from 3 individuals, with a Cmax of 23 ng·ml–1 and a mean AUCo-t of 84 ng·ml–1·h. TA was not detectable in 5 subjects and it was at the limit of detection (2 ng·ml–1) in 3 subjects. Pharmacokinetic analysis was not possible in any of those individuals.The reason for the interaction appears to be the adsorption of TA by SASP. An interval of 2–3 h should elapse between giving SASP and other drugs. |
| |
Keywords: | Talinolol Sulfasalazine /content/w813v27437vk2u07/xxlarge946.gif" alt=" beta" align=" MIDDLE" BORDER=" 0" >-adrenoceptor-blocking drugs absorption drug interaction kinetics |
本文献已被 SpringerLink 等数据库收录! |